ANTITHROMBOGENE IMPLANTATE

Patent europeic · EP2999494 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2999494
Numer da la dumonda
EP14800261
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-05-2014
Publitgà
30-03-2016
Concedì
16-09-2020
La protecziun finescha il pli tard
18-05-2034
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
A61L 31/08 (2006.01)
Prioritad
US 201361825256 P 20.05.2013
Dumonda PCT
PCT/US2014/038597 19.05.2014
Publicaziun PCT
WO2014/189835 27.11.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 09-06-2023

    Midada

    Published in Swissreg on 09.06.2023

  4. 01-10-2020

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 01.10.2020

  5. 16-09-2020

    Concedì

    Published in Swissreg on 16.09.2020

Partidas

Possessur

YALE UNIVERSITY

Yale University

Two Whitney Avenue, New Haven, CT 06511, US

Represchentant

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventur

NIKLASON, Laura

Greenwich, Connecticut 06831, US

DIMITRIEVSKA, Sashka

Branford, Connecticut 06405, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.